Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 23012-14-8 | MDL No. : | MFCD04114940 |
Formula : | C6H7NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UBESIXFCSFYQNK-UHFFFAOYSA-N |
M.W : | 141.13 | Pubchem ID : | 2763217 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 32.59 |
TPSA : | 52.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.53 cm/s |
Log Po/w (iLOGP) : | 1.74 |
Log Po/w (XLOGP3) : | 0.89 |
Log Po/w (WLOGP) : | 0.85 |
Log Po/w (MLOGP) : | -0.43 |
Log Po/w (SILICOS-IT) : | 0.94 |
Consensus Log Po/w : | 0.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.45 |
Solubility : | 5.03 mg/ml ; 0.0357 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.57 |
Solubility : | 3.77 mg/ml ; 0.0267 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.69 |
Solubility : | 2.86 mg/ml ; 0.0203 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | Stage #1: With formic acid In tetrahydrofuran for 0.5 h; Stage #2: With triethylamine In tetrahydrofuran at 20℃; for 1 h; Heating / reflux |
To a sol. of formic acid (8.62 mL, 228 mmol) in dry THF (200 mL) was added portionwise CDI (37.05 g, 228 mmol), whereas a gas evolution occurred. The mixture was stirred for 30 min, and a sol. of ethyl isocyanoacetate (25 mL, 228 mmol) in Et3N (60.5 mL, 434mmol) was added to the reaction mixture. The mixture was stirred at rt for 1 h, then under reflux overnight. The reaction mixture was allowed to cool to rt. Water was added, and the mixture was extracted with Et2O (3x). The combined org. extracts were dried over MgSO4, filtered and concentrated. Purification of the residue by FC (EtOAc / heptane; 1:5 -> 1:3 - 1:1) yielded the title compound (27.2 g, 84percent). LC-MS: tR = 0.58, ES+: 142.07. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With methanol; lithium borohydride; at 0 - 25℃; for 2h;Inert atmosphere; | (1) Add 6.8 g of ethyl 4-oxazolecarboxylate (A-1b) and 204 ml of methanol to the reaction vessel, cool to 0 C, add 1.7g of lithium borohydride, replace with nitrogen, stir at 25 C for 2 hours, and react The solution was quenched with water, concentrated to remove the organic solvent, and the residue was extracted with dichloromethane. The organic phase was washed, dried, and filtered.The filtrate was concentrated and purified by column chromatography to obtain 4-hydroxymethyloxazole compound (A-2b) (4.6 g of pale yellow oil, yield 95%); |
72% | With lithium triethylborohydride; In tetrahydrofuran; at -78 - 20℃; for 0.166667h; | To a sol. oxazole-4-carboxylic acid ethyl ester (26.66 g, 189 mmol) in THF (550 mL) was added dropwise at -78 C LiBHEt3 (1M in THF, 341 mL, 341 mmol). When the addition was complete, the mixture was stirred for 10 min at -78 C, then was allowed to warm to rt. When the reaction mixture had reached rt, it was concentrated under reduced pressure and was diluted with Et2O. The mixture was washed with little water. The org. extracts were dried over MgSO4, filtered and concentrated under reduced pressure. Purification of the residue by FC (CH2Cl2/MeOH 99:1 -> 97:3 -> 95:5 -> 93:7) yielded the title compound (13.5 g, 72%). LC-MS: tR = 0.20, ES+: 141.08. |
56% | To a solution of ethyl oxazole-4-carboxylate (1.0 g, 7.1 mmol) in THF (20 mL) was added LAH (330 mg, 8.5 mmol) portion wise at 0 C. After stirring at 0 C for 30 mi H20 (0.3 mL), 15% NaOH (0.3 mL) and H20 (0.9 mL) were then added dropwise at 0 C. The mixture was stirred at room temperature for another 20 mm, dried over MgSO4 and filtered. The filtrate was concentrated to give oxazol-4-ylmethanol (390 mg, yield: 56%) as yellow oil. ?H NIVIR (300 IVIHz, CDC13): oe = 7.90 (s, 1H), 7.64 (d, J= 0.3 Hz, 1H), 4.63 (s, 2H). |
56% | With sodium tetrahydroborate; In tetrahydrofuran; water; at 0 - 25℃; for 72h; | Step 1 : Preparation of oxazol-4-ylmethanol. [0743] To a solution of ethyl oxazole-4-carboxylate (2.00 g, 14.2 mmol in THF (20 mL)/H20 (3 mL) was added NaBFL (1.07 g, 28.3 mmol) at 0 C and then the mixture was stirred at 25 C for 72 h. A white cloudy was formed. To the mixture was added anhydrous Na2S04 (20 g) and the mixture was stirred at 25 C for 1 hour. The mixture was filtered and the cake was washed with MTBE (20 mL). The combined organic layer was concentrated to dryness. The residue was purified by Combi Flash (EtOAc in pentane from 10% to 100%) to give oxazol-4-ylmethanol (800 mg, 56% yield) as colorless oil. NMR (400 MHz, CDCh) d 2.52 (1H, brt, J= 5.6 Hz), 4.64 (2H, d, J = 5.6 Hz), 7.64 (1H, d, J= 0.8 Hz), 7.89 (1H, s). |
27% | With lithium aluminium tetrahydride; In tetrahydrofuran; at -78 - 0℃; for 3h; | Reference Example 29; 1,3-Oxazol-4-ylmethanol; To a suspension of lithium aluminum hydride (2.69 g, 70:9 mmol) in tetrahydrofuran (50 ml) was added dropwise a solution of ethyl 1,3-oxazole-4-carboxylate (5.00 g, 35.4 mmol) in tetrahydrofuran .(50 ml) at-78C. The reaction.mixture was stirred at the same temperature for 2 hrs, and the temperature was gradually raised to 0C. After stirring for 1 hr, water (2.7 ml) was added, then 15% aqueous sodium hydroxide solution (2.7 ml) and then water (8.1 ml) were added and the mixture was stirred. The reaction mixture was dried over anhydrous MgS04, the precipitate was filtered off through celite, and the filtrate was concentrated. The residue was subjected to silica gel column chromatography and eluted with ethyl acetate to give the title compound (930 mg, 27%) as a colorless oil. ¹H-NMR (CDCl3) No.: 3.27 (lH, br s), 4.64 (2H, s), 7.64 (lH, s) , 7.90 (lH, s). |
With diisobutylaluminium hydride; In tetrahydrofuran; hexanes; at -78 - 0℃; | B. 1,3-Oxazol-4-ylmethanol To a solution of ethyl 1,3-oxazole-4-carboxylate (0.178 g, 1.26 mmol) in anhydrous THF (5 mL) at -78 C. was added DIBAL-H (2.52 mL of a 1.0 M solution in hexanes, 2.52 mmol), dropwise over 3 min. After 1 h, the cooling bath was removed, and the solution warmed to 0 C. After stirring 2.5 h at 0 C., the reaction was quenched with MeOH, MgSO4 (ca. 0.3 g) was added and the mixture stirred 30 min. The whole mixture was filtered through Celite (EtOAc wash), concentrated in vacuo and allowed to stand at rt over night. The residue was slurried in EtOAc and filtered again through Celite. The filtrate was concentrated in vacuo, affording 0.103 g of the title compound as a pale yellow oil which was used without further purification: 1H NMR (400 MHz, CDCl3) delta 7.90 (s, 1H), 7.64 (app. q, J=0.9 Hz, 1H), 4.64 (d, J=6.0 Hz, 2H), 3.40 (t, J=6.1 Hz, 1H). | |
PREPARATION 77; Oxazol-4-yl-methanol; DIBAL-H (56 ml of a 1.0 M solution in toluene) was added drop-wise over 15 minutes to a solution of oxazole-4-carboxylic acid ethyl ester (7.50 g, 53.1 mmol) in THF (140 ml) at -78 C. The resulting solution was stirred at -78 C. for 30 min and then further DIBAL-H (56 mL of a 1.0 M solution in toluene, 56.0 mmol) was added over 15 minutes. The reaction was then left to slowly warm from -78 C. to room temperature for 16 hours. The resulting bright yellow solution was cooled to 0 C. in an ice bath and Na2SO4.10 H2O (15.9 g-equal weight to DIBAL-H added) was added in small portions (CARE-slow addition to prevent exotherm) to cause precipitation of aluminium salts. The mixture was left to warm to room temperature and after stirring for 90 mins the resulting suspension was filtered through a layer of celite. The celite plug was rinsed with dichloromethane (3×100 mL) and methanol (2×100 mL) and the filtrates were combined. The solvent was removed under reduced pressure, providing the title compound (4.8 g) as a brown oil.1H NMR (400 MHz, CHLOROFORM-d) delta ppm 4.60 (s, 2 H), 7.6 (s, 1 H), 7.9 (s, 1 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-Bromosuccinimide;1,1'-azobis (cyclohexanecarbonitrile); In tetrachloromethane; | Bromination of compound 22 with one equivalent of N-bromosuccinimide in the presence of 1,1'-azobis(cyclohexanecarbonitrile) in CCl4 gives the corresponding 5-bromo derivative (compound 23). It has been found (53-55) that the nuclear bromination of oxazoles either with bromine or with N-bromosuccinimide occurs preferentially at C-5; if this position is occupied, then at C-4, but not at C-2. Selective ammonolysis of compound 23 with methanolic ammonia (saturated at 0 C.) at controlled temperature yields 5-bromo-1,3-oxazole-4-carboxamide (compound 24). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | To a sol. of formic acid (8.62 mL, 228 mmol) in dry THF (200 mL) was added portionwise CDI (37.05 g, 228 mmol), whereas a gas evolution occurred. The mixture was stirred for 30 min, and a sol. of ethyl isocyanoacetate (25 mL, 228 mmol) in Et3N (60.5 mL, 434mmol) was added to the reaction mixture. The mixture was stirred at rt for 1 h, then under reflux overnight. The reaction mixture was allowed to cool to rt. Water was added, and the mixture was extracted with Et2O (3x). The combined org. extracts were dried over MgSO4, filtered and concentrated. Purification of the residue by FC (EtOAc / heptane; 1:5 -> 1:3 - 1:1) yielded the title compound (27.2 g, 84%). LC-MS: tR = 0.58, ES+: 142.07. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.3 g | With caesium carbonate; tris-(o-tolyl)phosphine; In 1,4-dioxane; water; at 80℃; for 2h;Inert atmosphere; | To a stirred suspenstion of 2-bromopyridine (500 mg, 3.1847 mol, leq), <strong>[23012-14-8]ethyl oxazole-4-carboxylate</strong> (500 mg, 3.184 mmol, leq), CS2CO3 (2.5e q, 2.59 gm, 7.96 mmol) in dioxane (10 mL) and water (2 mL) was purged with nitrogen for 5 minutes. P(o-tolyl)3 (193.6 mg, 0.63 mmol, 0.2 eq) was added to the reaction mixture, which was heated to 80 C for 2 hours. The cooled reaction mixture was diluted with water, and then extracted with EtOAc. The combined EtOAc extracts was washed with water, dried over Na2S04, filtered through pad of silica gel and concentrated. The residue was purified by using silica gel (eluting with 5-40% EtO Ac/hexanes) to give ethyl 2-(pyri din-2 -yl)oxazole-4-carboxylate (0.3 g). LCMS: 220 [M+H] +. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With palladium diacetate; caesium carbonate; CyJohnPhos; In 1,4-dioxane; at 110℃; for 18h;Inert atmosphere; | General procedure: Oxazole or thiazole-4-carboxylate derivative (0.35mmol or 0.27mmol) was placed in a dried-oven sealed tub (10ml) containing a magnetic stir bar with Pd(OAc)2 (5mol%), ligand (10mol%) and carbonate base (2equiv). A solution of halide (1equiv) in dry dioxane or DMF (1ml) was added. The resulting mixture was purged with nitrogen and stirred at 110C for 18h. After filtration on Celite and concentration under vacuo, the crude product was purified by flash column chromatography on silica gel using a mixture of petroleum ether-Ethyl acetate as eluent to give pure arylated products 1b-d and 2b-d. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
0.19 g | With palladium diacetate; caesium carbonate; CyJohnPhos; In tetrahydrofuran; at 110℃; for 18h;Inert atmosphere; | Reference Production Example 302 (0945) Palladium acetate (28 mg, 0.13 mmol), (2-biphenyl)dicyclohexylphosphine (88 mg, 0.25 mmol) and cesium carbonate (1.63 g, 5.0 mmol) were added to tetrahydrofuran (7 mL). Ethyl oxazole-4-carboxylate (0.35 g, 2.5 mmol) and 1-bromobutane (0.69 g, 5.0 mmol) were added to the mixed liquid at room temperature. The air in the reaction vessel was replaced with nitrogen, and then the mixture was stirred at 110C for 18 hours. Water was added to the reaction mixture, and the mixture was extracted three times with ethyl acetate. The organic layer was washed with saturated saline water, dried over anhydrous sodium sulfate and then filtered, and the filtrate was concentrated under reduced pressure. The residue was applied to a silica gel column chromatography to obtain 0.19 g of ethyl 2-butyl-oxazole-4-carboxylate represented by the following formula. 1H-NMR(CDCl3, TMS, delta(ppm)) :0.93(3H, t), 1.33-1.43(5H, m), 1.72-1.81(2H, m), 2.82(2H, t), 4.39(2H, q), 8.14(1H, s) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With tributylphosphine; palladium diacetate; caesium carbonate; In 1,4-dioxane; at 110℃; for 18h;Inert atmosphere; | General procedure: Oxazole or thiazole-4-carboxylate derivative (0.35mmol or 0.27mmol) was placed in a dried-oven sealed tub (10ml) containing a magnetic stir bar with Pd(OAc)2 (5mol%), ligand (10mol%) and carbonate base (2equiv). A solution of halide (1equiv) in dry dioxane or DMF (1ml) was added. The resulting mixture was purged with nitrogen and stirred at 110C for 18h. After filtration on Celite and concentration under vacuo, the crude product was purified by flash column chromatography on silica gel using a mixture of petroleum ether-Ethyl acetate as eluent to give pure arylated products 1b-d and 2b-d. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With (IPr)PdCl[2-(pyridin-2-yl)acetate]; lithium tert-butoxide; In N,N-dimethyl-formamide; at 130℃; for 12h; | General procedure: The direct arylation reactions were carried out under aerobicconditions. In the parallel reaction, aryl bromide (0.5 mmol),(benzo)oxazoles (0.75 mmol), LiOtBu (1.0 mmol) and the NHC-PdCl-[(2-pyridyl)alkyl carboxylate] complex (1% mol) and DMF(2.0 mL) were introduced in a reaction tube. The reaction mixturewas stirred for 12 h at 130 C. After completion of the reaction, thereaction mixture was cooled to room temperature and then evaporatedunder vacuum. The residue was subjected to purification viacolumn chromatography with petroleum ether-EtOAc (20:1) aseluent to give the products. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With (IPr)PdCl[2-(pyridin-2-yl)acetate]; lithium tert-butoxide; In N,N-dimethyl-formamide; at 130℃; for 12h; | General procedure: The direct arylation reactions were carried out under aerobicconditions. In the parallel reaction, aryl bromide (0.5 mmol),(benzo)oxazoles (0.75 mmol), LiOtBu (1.0 mmol) and the NHC-PdCl-[(2-pyridyl)alkyl carboxylate] complex (1% mol) and DMF(2.0 mL) were introduced in a reaction tube. The reaction mixturewas stirred for 12 h at 130 C. After completion of the reaction, thereaction mixture was cooled to room temperature and then evaporatedunder vacuum. The residue was subjected to purification viacolumn chromatography with petroleum ether-EtOAc (20:1) aseluent to give the products. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With isopentyl nitrite; In tetrahydrofuran; at 120℃; under 5250.53 Torr; for 0.333333h; | General procedure: A solution of the selected heterocyclic starting material (1.00 mmol) in THF (10 mL) and a solutionof isopentyl nitrite (141 mg, 1.20 mmol) in THF (10 mL) were both pumped at a flow rate of 0.25 mLmin1 with a Vapourtech ?Easy MedChem V3? system, meeting at a PTFE T-piece and the outputflowing through a 10.0 mL coil reactor maintained at 120 C, giving a residence time of 20 min.The pressure of the system was maintained at 7 bar with a back-pressure regulator. For compoundswhere an isolated yield was reported: the output mixture was concentrated under reduced pressureto give an oil (or powder). The oil (or powder) was purified using column chromatography withvarious mixtures of ethyl acetate and hexane as the eluent, or by recrystallisation using methanol, togive isolated compounds that showed no impurities by NMR spectroscopy. For compounds where aconversion was reported (due to volatility of products), the output mixture was carefully concentratedunder a reduced pressure of 100 mbar for 10 min and the conversion was calculated by integration ofproduct peaks to a quantified internal standard (nitrobenzene). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With palladium diacetate; | Example 196 Synthesis of ethyl 2-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)oxazole-4-carboxylate. The mixture of 2-(chloromethyl)-6-cyclopropylimidazo[1,2-a]pyridine (2.06 g, 10.0 mmol), ethyl oxazole-4-carboxylate (2.82 g, 20.0 mmol), (2-biphenyl)dicyclohexylphosphine (350 mg, 1.0 mmol), Pd(OAc)2 (224 mg, 1.0 mmol) and Cs2CO3 (6.52 g, 20.0 mmol) in dioxane (30 mL) was degassed with N2 and stirred at 100 C. for 18 h. The reaction mixture was cooled to RT and diluted with H2O (100 mL). Then extracted with EtOAc (100 mL*3). The combined organic layer was washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash column chromatography to afforded ethyl 2-((6-cyclopropylimidazo[1,2-a]pyridin-2-yl)methyl)oxazole-4-carboxylate (420 mg, yield: 13.5%) as a brown oil. ESI-MS [M+H]+: 312.3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With palladium diacetate; caesium carbonate; tris-(o-tolyl)phosphine; In N,N-dimethyl-formamide; at 70℃; for 17h;Inert atmosphere; | A mixture of <strong>[207799-10-8]tert-butyl N-(4-bromo-2-pyridyl)carbamate</strong> (1.00 g, 3.66 mmol, CAS207799-10-8), ethyl oxazole-4-carboxylate (517 mg, 3.66 mmol, CAS170487-38-4), tris-o-tolylphosphane (223 mg, 732 umol), Pd(OAc)2 (82.2 mg, 366 umol) and Cs2CO3 (2.39 g, 7.32 mmol) in DMF (10 mL) was degassed and purged with N2 3 times, and then the mixture was stirred at 70 C. for 17 hrs under N2 atmosphere. On completion, the mixture was diluted with water (300 mL), and extracted with EA (3×200 mL). The organic layer was washed with water (400 mL), dried over Na2SO4, filtrated and concentrated in vacuo to give the title compound (1.22 g, 50% yield) as a yellow solid. LC-MS (ESI+) m/z 278.2 (M+H-56)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With palladium diacetate; caesium carbonate; tris-(o-tolyl)phosphine; In N,N-dimethyl-formamide; at 70℃; for 12h;Inert atmosphere; | To a solution of 4-bromo-2-cyclopropyl-pyridine (512 mg, 2.59 mmol, CAS1086381-28-3) and ethyl oxazole-4-carboxylate (365 mg, 2.59 mmol, CAS170487-38-4) in DMF (5 mL) was added tris-o-tolylphosphane (157 mg, 517 umol), Pd(OAc)2 (58.0 mg, 259 umol) and Cs2CO3 (1.68 g, 5.17 mmol). The reaction mixture was stirred at 70 C. for 12 hours under nitrogen. On completion, the reaction mixture was diluted with EA (100 mL), poured into sat.NH4Cl (50 mL) and extracted with EA (3×50 mL). The combined organic layers were washed with brine (50 mL), dried with anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was purified by silica column chromatography (PE/EA, 10/1 to 5/1) to give the title compound (380 mg, 55% yield) as a white solid. 1H NMR (400 MHz, DMSO-d6) delta 8.57 (d, J=4.8 Hz, 1H), 8.33 (s, 1H), 7.82 (s, 1H), 7.67 (dd, J=1.6, 5.2 Hz, 1H), 4.44 (q, J=7.2 Hz, 2H), 2.16-2.07 (m, 1H), 1.42 (t, J=7.2 Hz, 3H), 1.12-1.02 (m, 4H). LC-MS (ESI+) m/z 259.1 (M+H)+. |
[ 10200-43-8 ]
Ethyl 2-methyloxazole-4-carboxylate
Similarity: 0.88
[ 177760-52-0 ]
Ethyl 2-aminooxazole-4-carboxylate
Similarity: 0.85
[ 85806-67-3 ]
Methyl 2-methyloxazole-4-carboxylate
Similarity: 0.85
[ 460081-20-3 ]
Ethyl 2-bromooxazole-4-carboxylate
Similarity: 0.84
[ 32968-44-8 ]
Ethyl 5-methyloxazole-4-carboxylate
Similarity: 0.84
[ 10200-43-8 ]
Ethyl 2-methyloxazole-4-carboxylate
Similarity: 0.88
[ 177760-52-0 ]
Ethyl 2-aminooxazole-4-carboxylate
Similarity: 0.85
[ 85806-67-3 ]
Methyl 2-methyloxazole-4-carboxylate
Similarity: 0.85
[ 460081-20-3 ]
Ethyl 2-bromooxazole-4-carboxylate
Similarity: 0.84
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :